http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111848725-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-0819 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-093 |
| filingDate | 2019-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2023-01-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2023-01-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-111848725-B |
| titleOfInvention | Preparation, activity and application of theanyltetrahydroimidazopyridine-6-carboxyl basic amino acid |
| abstract | The invention discloses (6S)-5-theanyl-4,5,6,7-tetrahydro-3H-imidazo[4,5-c]pyridine-6-formyl-AA of the following formula (AA is Basic amino acid residues, i.e. L-lysine residues and L-arginine residues), disclose their preparation, disclose their antithrombotic activity, disclose their thrombolytic activity and disclose their It has a 24-hour therapeutic effect on treating stroke, so the present invention discloses its application in the preparation of antithrombotic drugs, thrombolytic drugs and drugs for treating ischemic stroke. |
| priorityDate | 2019-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 66.